BIOMAT Database Logo BIOMAT Database Logo

Antibodies to human T cell leukaemia virus-associated membrane antigens in haemophiliacs: evidence for infection before 1980. 1983

B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex

Human T cell leukaemia virus (HTLV), HTLV proviral DNA, and antibodies to HTLV or a related agent have recently been detected in patients with acquired immunodeficiency syndrome (AIDS). Antibodies against HTLV-related antigens were assayed by means of indirect living cell immunofluorescence of HTLV-infected cells in sera recently collected from Georgia haemophiliacs and in sera collected between 1976 and 1981 from New York haemophiliacs. 5 of 45 Georgia haemophiliacs and 8 of 48 New York haemophiliacs had antibodies to HTLV-associated cell membrane antigen (HTLV-MA). None of the control Georgia patients on haemodialysis or with chronic hepatitis had detectable antibodies. The 5 haemophiliac patients from Georgia with HTLV-MA had significantly fewer T4 lymphocytes than similar HTLV-MA-negative patients. There were no other significant immunological differences between these groups. These data suggest that transfusions with blood products may expose haemophiliacs to a substantial risk of acquiring HTLV or a related virus.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009519 New York City City located at the mouth of the Hudson River, in New York State.
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005845 Georgia A state located in the southeastern United States, The capital is Atlanta.
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs.
January 1984, Nature,
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Antibodies to human adult T cell leukaemia virus type I associated antigens in Swedish leukaemia patients and blood donors.
July 1985, British journal of haematology,
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS.
May 1983, Science (New York, N.Y.),
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection.
June 1984, Proceedings of the National Academy of Sciences of the United States of America,
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Antibodies to human T-cell leukemia virus-membrane antigens in macaques with malignant lymphoma.
January 1985, Haematology and blood transfusion,
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Infection control: human T-cell leukaemia virus infection.
January 1996, British journal of nursing (Mark Allen Publishing),
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Identification of membrane antigens important for adsorption of human T-cell leukaemia virus type I.
January 1998, Research in virology,
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
January 1986, Vox sanguinis,
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Antibodies to human T-cell lymphotropic virus-I membrane antigens and inverted T4/T8 ratios in hemophiliacs.
April 1985, American journal of clinical pathology,
B L Evatt, and S F Stein, and D P Francis, and D N Lawrence, and M F McLane, and J S McDougal, and T H Lee, and T J Spira, and C Cabradilla, and J I Mullens, and M Essex
Passively transmitted antibodies to human immunodeficiency virus in haemophiliacs.
January 1988, Vox sanguinis,
Copied contents to your clipboard!